Brief: Sprint Bioscience Q2 Net Sales Up At SEK 16.7 Mln
Aug 28 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 NET SALES DURING THE QUARTER AMOUNTED TO SEK 16.7 (0)
MILLION
* Q2 OPERATING RESULT FOR THE QUARTER AMOUNTED TO SEK -5.6
(-11.8)
MILLION
Source text for Eikon: ID:nMFN7fKSCp
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program